Brief: Annexon Reports Third Quarter 2022 Financial Results
03/11/2022 11:57
Nov 3 (Reuters) - Annexon Inc ANNX.O :
* ANNEXON REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PLANS
TO PROVIDE UPDATES ON COMPLEMENT THERAPEUTIC PORTFOLIO IN
JANUARY 2023
* QTRLY LOSS PER SHARE $0.51
* CO TO PROVIDE PORTFOLIO UPDATES ACROSS AUTOIMMUNE,
NEURODEGENERATION AND OPHTHALMOLOGY THERAPEUTIC FRANCHISES IN
EARLY JANUARY
Source text for Eikon: ID:nGNX9pNQXd
Further company coverage: ANNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Annexon
See all newsBrief: Annexon Reports Inducement Grants to New Employees
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Annexon, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte